Daniel Vasella

Daniel Lucius Vasella is Vice Chairman at ImmunOs Therapeutics AG since 2022.
Holds the Chairman position at Clade Therapeutics, Inc. Serves as Independent Director at PepsiCo, Inc. since 2002.
Director roles include INSEAD, XBiotech USA, Inc. since 2014, Numab Therapeutics AG since 2019, mPharma Health Nigeria Ltd. since 2019, mPharma Data, Inc., Topadur Pharma AG since 2020, and Eclipse Bioinnovations, Inc. Advisor at KBL Healthcare Ventures.
Member of the International Governors Board at The Peres Center for Peace since 2013.
Former roles include Vice Chairman & Chief Executive Officer at Novartis India Ltd. Chairman at Novartis International AG and Novartis AG from 2010 to 2013.
Chairman at Alcon Laboratories, Inc. and Novartis Pharmaceuticals Corp.
Independent Director at XBiotech, Inc. from 2014 to 2018.
Non-Executive Director at SciClone Pharmaceuticals (Holdings) Ltd. from 2020 to 2024.
Independent Director at American Express Co. from 2012 to 2026.
SVP, Chief Executive & Operating Officer at Novartis Pharmaceuticals UK Ltd. from 1988 to 1996.
Senior VP, Chief Executive & Operating Officer at Sandoz Pharmaceuticals Corp.
from 1988 to 1992.
Member of the American Academy of Arts & Sciences.
Trustee at Carnegie Endowment for International Peace.
Earned a doctorate from the University of Bern in 1980.